Discover
CBIO
Crescent Biopharma, Inc.
17.08
2 x 13.14
2 x 21.79
bid
ask
-
0.92
5.11%
2 @ 04:00 PM
16.95 -0.13 (0.76%)
| Ytd | 44.01% | |
| 1y | 5.76% |
16.97
day range
18.52
8.72
52 week range
27.41
| Open | 18.00 | Prev Close | 18.00 | Low | 16.97 | High | 18.52 | Mkt Cap | 470.98M |
| Vol | 179.07K | Avg Vol | 315.55K | EPS | -5.88 | P/E | N/A | Forward P/E | -17.04 |
| Beta | 1.29 | Short Ratio | 0.19 | Inst. Own | 8.75% | Dividend | 15.94 | Div Yield | 792.92 |
| Ex Div Date | 01-13 | Earning | N/A | 50-d Avg | 19.49 | 200-d Avg | 14.47 | 1yr Est | 0.00 |
CBIO News
globenewswire.com
Crescent Biopharma Announces Grants of Inducement Awards
WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Compa
benzinga.com
This Craig-Hallum Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Analysts downgraded ratings on Cardiff Oncology, Crescent Biopharma, Corsair Gaming, Equity Resident